This week’s episode is going to include a great contrast between the short targets.

On one hand, we will see a complex target composed of a Canadian retailer that is facing several fundamental issues. This could lead to credit downgrade which should present a downside.

On the other hand, we have my favorite biotech, Enochian Biosciences whose head scientist pleaded guilty to commercial burglary and is a support of the Spoon Bender, a magician who allegedly can bend spoons with his mind. Over the past two weeks, White Diamond Research found new information that makes ENOB the craziest and most overvalued biotech that WDR has ever seen.

I would also like to thank Breakout Point for data that I used in preparation for the podcast. Breakout Point is a great software tool for investors interested in tracking ongoing short campaigns.

Tickers & Reports

Spruce Point on Canadian Tire Corp. (CTC)

White Diamond on Enochian Biosciences (ENOB)

Blue Orca on Kasen (HK.0496)